Kangmei Pharma | 600518 - Interest Income

Stock Price
1.71
Daily Change
0 0%
Monthly
-2.84%
Yearly
-10.94%
Q2 Forecast
1.69

Kangmei Pharma reported CNY1.81M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Genomma Lab Internacional MXN 35.76M 12.92M Mar/2026
Hypermarcas BRL 11.53M 4.65M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 11M 2M Dec/2025
Jiangsu Hengrui CNY 288.66M 111.14M Dec/2025
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Moderna USD 73M 8M Sep/2025
Revvity USD 0.4 8.34M Sep/2025
Sh Fosun Pharma CNY 87.03M 10.62M Jun/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
WuXi AppTec CNY 259.88M 20.13M Dec/2025
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025